| Breakdown | TTM | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.94B | 26.62B | 25.02B | 21.59B | 12.17B | 1.91B |
| Gross Profit | 8.01B | 7.88B | 9.38B | 7.28B | 412.00M | -2.75B |
| EBITDA | 7.06B | 6.91B | 6.23B | 4.37B | -2.20B | -5.69B |
| Net Income | 3.09B | 2.76B | 1.92B | -74.00M | -6.09B | -9.50B |
Balance Sheet | ||||||
| Total Assets | 51.42B | 51.64B | 48.28B | 49.12B | 51.70B | 53.34B |
| Cash, Cash Equivalents and Short-Term Investments | 1.42B | 1.93B | 1.21B | 2.42B | 4.03B | 9.14B |
| Total Debt | 26.53B | 27.97B | 28.88B | 31.89B | 35.88B | 34.61B |
| Total Liabilities | 38.41B | 39.37B | 39.03B | 42.24B | 44.64B | 41.20B |
| Stockholders Equity | 12.99B | 12.27B | 9.25B | 6.88B | 7.06B | 12.14B |
Cash Flow | ||||||
| Free Cash Flow | 3.01B | 2.61B | 1.30B | 997.00M | -6.61B | -7.72B |
| Operating Cash Flow | 6.59B | 6.22B | 5.92B | 4.28B | -1.67B | -4.11B |
| Investing Cash Flow | -3.32B | -3.32B | -4.54B | -2.81B | -4.77B | -3.54B |
| Financing Cash Flow | -2.68B | -2.19B | -2.58B | -5.09B | 3.58B | 6.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £2.20B | 1.18 | 24.73% | 1.18% | 7.17% | -2.22% | |
69 Neutral | $20.80B | 28.60 | -23.50% | 1.23% | 5.55% | 19.27% | |
66 Neutral | £4.12B | 6.31 | 7.68% | 3.80% | -2.12% | 8.95% | |
64 Neutral | £247.50M | 15.55 | 5.43% | 1.39% | -5.30% | -30.17% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | £28.70B | 42.42 | 26.22% | ― | 3.46% | 33.88% | |
54 Neutral | £694.81M | 56.99 | 4.65% | 1.84% | 6.14% | 1.27% |